Silo Pharma, Inc. (SILO)
5.251
+0.26
(+5.26%)
USD |
NASDAQ |
Jun 02, 16:00
0.3519
-4.90
(-93.30%)
After-Hours: 20:00
Silo Pharma EPS Diluted (Quarterly) : -0.1202 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Savara, Inc. | -0.1472 |
| Vericel Corp. | -0.1241 |
| Biogen, Inc. | 2.153 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.647M |
| Revenue (Quarterly) | 0.018M |
| Total Expenses (Quarterly) | 1.665M |
| Enterprise Value | -0.5796M |
| Gross Profit Margin (Quarterly) | -1.38K% |
| Profit Margin (Quarterly) | -9.15K% |
| Earnings Yield | -9.47% |
| Normalized Earnings Yield | -9.274 |